GNN on Google Play Store GNN on Apple App Store
Connect with us

Pakistan

IAS 2023 gives hope to those living with HIV

The IAS 2023 had four days of enrichment and discovery in Brisbane, with more than 1,400 abstract presentations that include cutting-edge evidence and stretch across the spectrum of science.

Published

11 months ago

on

By

IAS 2023 gives hope to those living with HIV
GNN Media: Representational Photo

By Sania Chuhdary 

Brisbane: The International Aid Society (IAS) Conference 2023, held in Brisbane, came to a successful conclusion with the global community benefiting from valuable insights and key takeaways to combat HIV.

Distinguished scholars, professionals, and experts from diverse backgrounds and fields showcased their unique ideas and research dedicated to the ongoing fight against the virus.

The IAS 2023 had four days of enrichment and discovery in Brisbane, with more than 1,400 abstract presentations that include cutting-edge evidence and stretch across the spectrum of science.

There were 60 thought-provoking symposia and oral abstract sessions, featuring captivating keynote presentations and expert-led invited-speaker sessions. The participants presented their research and  discussed the virus with different aspects but here are the key takeaways from the IAS 2023.

Undetectable Equals Untransmittable: Zero Risk of Transmission

One of the prominent highlights from the conference was a research-based testament from the World Health Organization (WHO), affirming that "Undetectable HIV has zero risk of sexual transmission." This groundbreaking finding serves as a powerful boost to the undetectable equals untransmittable (U=U) messaging, bringing hope to those living with HIV.

Addressing HIV Vulnerability in Conflict-hit Areas:

Experts engaged in lengthy discussions and interesting debates on various aspects of HIV, including its association with stigmatization and criminization, cures, and prevention methods. The conference also shed light on the vulnerability of people, especially women, to HIV in conflict-hit areas. Displaced individuals, particularly women, faced higher risks of HIV, often compounded by gender-based violence (GBV). The need for targeted support and interventions to address this issue was highlighted during the event.

Intersections of HIV, COVID-19, and Mpox

The World Health Organization (WHO) presented critical analyses on the intersections between HIV, COVID-19, and mpox, emphasizing the importance of equitable vaccine access.

Data from the WHO Global Clinical Platform revealed that vaccination significantly reduced mortality due to COVID-19 among HIV-negative individuals.

However, people living with HIV, especially those with low CD4 counts, experienced only a modest reduction in mortality during the Omicron and Delta waves. The conference underscored the importance of implementing WHO recommendations for booster vaccine doses for all people living with HIV.

Game-changer for Heart Disease Detection

Participants at IAS 2023 were introduced to groundbreaking results from the Randomized Trial to Prevent Vascular Events (REPRIEVE) trial. The study revealed that daily intake of pitavastatin, a statin, by people living with HIV lowered their likelihood of major adverse cardiovascular events by an impressive 35%. This discovery offers new hope in managing cardiovascular disease in individuals living with HIV.

Protection through Research: Focus on Pregnant and Breastfeeding Women:

 HIV remains a significant global public health challenge, with approximately 38 million people living with the virus worldwide. The conference emphasized the critical need to prevent vertical transmission of HIV in children.

While effective antiretroviral therapy has reduced vertical transmission, challenges persist in providing optimal care for pregnant and breastfeeding women and newborns, especially in resource-limited settings.

The event called for increased investment in research, treatment, and prevention approaches to address these gaps and improve the care of vulnerable populations.

Pathways Linking Climate Change and HIV/AIDS:

A unique and vital discussion at IAS 2023 explored the links between climate change and HIV/AIDS. Experts pointed out that climate change not only disrupts health systems but also has indirect impacts on HIV care, from diagnosis to treatment. Extreme weather events can hinder HIV service delivery, lead to forced migration, and subsequently result in interruptions to HIV treatment adherence and poorer health outcomes. Additionally, food insecurity resulting from climate-related events can contribute to risky sexual behaviors, increasing the risk of HIV infection.

The conference highlighted the importance of integrating climate change considerations into HIV/AIDS responses and emphasized the need for comprehensive and adaptive strategies to safeguard the health and well-being of those living with HIV in a changing climate.

Continue Reading

Trending